<DOC>
	<DOCNO>NCT00653601</DOCNO>
	<brief_summary>Patients undergone placement coronary stent require dual antiplatelet therapy Plavix aspirin prevent serious complication in-stent thrombosis . Some patient require surgery dual antiplatelet therapy . This pose challenge Plavix associate high risk perioperative bleeding , stop Plavix put patient increase risk in-stent thrombosis . Currently , ACC/AHA guideline recommend discontinuation Plavix five day prior surgery prevent bleeding complication . However , universal recommendation prevent in-stent thrombosis . Some expert recommend use glycoprotein IIb/IIIa inhibitor ( short-acting antiplatelet agent ) `` bridge therapy '' high-risk perioperative period . Although agent beneficial base theory , currently publish data effectiveness purpose . The current study proposes evaluate value Aggrastat ( short-acting intravenous platelet glycoprotein IIb/IIIa inhibitor ) decrease risk in-stent thrombosis without increase risk perioperative bleeding .</brief_summary>
	<brief_title>Bridging Therapy Patients High Risk Stent Thrombosis Undergoing Surgery</brief_title>
	<detailed_description>A. D/C clopidogrel 5 day prior surgery B . Continue ASA ( Increase dose 325 mg prohibitive bleeding risk ) C. Check baseline IIb/IIIa P2Y12 via Verify Now device prior initiating tirofiban D. Start Tirofiban 2 day prior procedure ( Patient MUST monitor bed ) - Load Tirofiban ONLY P2Y12 ( Verify Now Assay ) platelet inhibition &lt; 20 % OTHERWISE initiate continuous infusion dose - Creatinine clearance &gt; 30mL/min : Tirofiban 0.4 mcg/kg/min 30 minute , follow continuous infusion 0.1 mcg/kg/min - Creatinine clearance &lt; 30mL/min : Tirofiban 0.2 mcg/kg/min 30 minute , follow continuous infusion 0.05 mcg/kg/min E. Check steady state IIb/IIIa inhibitor verify assay ( &gt; 8 hour initiation ) F. Hold Tirofiban 12 hour prior procedure G. Check IIb/IIIa inhibitor verify assay ( 10-12 hour Tirofiban discontinue ) H. CBC pre post op I. Reload clopidogrel &gt; 24 hour post op ( 300 mg X 1 75 mg daily ) unless prohibitive bleeding risk J . Reduce ASA pre-procedure dose . Restart ASA , 24 hour port-op D/C prior procedure K. Check P2Y12 via Verify Now device post-loading dose clopidogrel ( test perform w/in 48 hour D/C IIb/IIIa inhibitor ( tirofiban )</detailed_description>
	<mesh_term>Thrombosis</mesh_term>
	<criteria>Patients ' BMS/DES plavix prior surgery need elective procedure Patients ' BMS/DES NOT plavix prior surgery need elective procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>GPI</keyword>
	<keyword>glycoprotein IIb/IIIa inhibitor</keyword>
	<keyword>Aggrastat</keyword>
	<keyword>Tirofiban</keyword>
	<keyword>Verify</keyword>
	<keyword>platelet function test</keyword>
	<keyword>bridge therapy</keyword>
</DOC>